The COVID-19 pandemic has changed the world in fundamental ways, and the biotechnology sector has been summoned to marshal its broad arsenal of next-generation weapons to beat this disease. As the world undergoes a change, so, too, does BIO.
BIO Chairman Jeremy Levin, Former President & CEO Jim Greenwood, and BIO's new President and CEO Michelle McMurry-Heath kicked off BIO Digital week with an engaging session on how the biotech sector is rising to meet the greatest public health challenge in a century.
Here are some highlights from their session:
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
